Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Medroxyprogesterone
Drug ID BADD_D01365
Description Not Available
Indications and Usage Not Available
Marketing Status Not Available
ATC Code G03AC06; G03DA02; L02AB02
DrugBank ID Not Available
KEGG ID D08166
MeSH ID D008525
PubChem ID 10631
TTD Drug ID D0I2SD
NDC Product Code 54348-805; 0009-0067
UNII HSU1C9YRES
Synonyms Medroxyprogesterone | (6 alpha)-17-Hydroxy-6-methylpregn-4-ene-3,20-dione | Pregn-4-ene-3,20-dione, 17-hydroxy-6-methyl-, (6alpha)- | 17 alpha-Hydroxy-6 alpha-Methylprogesterone | 17 alpha Hydroxy 6 alpha Methylprogesterone | Methylhydroxyprogesterone | Adgyn Medro
Chemical Information
Molecular Formula C22H32O3
CAS Registry Number 520-85-4
SMILES CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Cervix carcinoma21.06.02.001; 16.12.01.001--Not Available
Chest pain22.12.02.003; 08.01.08.002; 02.02.02.011--Not Available
Chills15.05.03.016; 08.01.09.001--
Chloasma23.05.01.001; 18.08.02.002--Not Available
Chorea17.01.01.001--Not Available
Cushing's syndrome14.11.01.007; 05.01.01.001; 24.08.04.001; 19.07.03.002--Not Available
Cushingoid24.08.02.004; 19.07.03.001; 14.11.01.006; 05.01.01.002--
Cystitis20.03.02.002; 11.01.14.001--
Dementia19.20.02.001; 17.03.01.001--Not Available
Depression19.15.01.001--
Dermatitis23.03.04.002--Not Available
Diarrhoea07.02.01.001--
Diplopia06.02.06.002; 17.17.01.005--Not Available
Discomfort08.01.08.003--Not Available
Dizziness02.11.04.006; 24.06.02.007; 17.02.05.003--
Dry skin23.03.03.001--
Dysmenorrhoea21.01.01.002--
Dyspareunia21.03.02.016; 19.08.05.004--
Dyspepsia07.01.02.001--
Dysphonia17.02.08.004; 22.12.03.006; 19.19.03.002--
Dyspnoea02.11.05.003; 22.02.01.004--
Ectropion of cervix21.06.01.004--Not Available
Embolism venous24.01.01.003--Not Available
Endometrial cancer16.12.02.001; 21.07.02.002--Not Available
Epilepsy17.12.03.002--Not Available
Erythema23.03.06.001--Not Available
Erythema multiforme23.03.01.003; 10.01.03.015--
Erythema nodosum23.07.02.001; 10.02.01.020--Not Available
Extravasation08.01.03.008--Not Available
Facial paralysis17.04.03.008--Not Available
The 2th Page    First    Pre   2 3 4 5 6    Next   Last    Total 6 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene